The Irish Shock to U.S. Manufacturing?
- Date Posted:
- Is Database:
- Database
The US pharmaceutical trade deficit has surged, surpassing the aerospace surplus, driven by imports from high-wage countries like Ireland & Switzerland. The deficit has more than doubled since 2006, escalating from $32bn to $93bn, about 0.4% of US GDP.
New Setser, the under the radar “Irish Shock.”
U.S. pharmaceutical output peaked back in 2006, pharma imports have been climbing since then but really jumped after the TCJA (the trade deficit in pharmaceuticals is on track to double between the start of 2018 (after the tax cuts) and the end of 2020) Brad’s in favor of using the tax code to end profit shifting that encourages the offshoring of high value add like pharmaceuticals

Brad Setser, "The Irish Shock to U.S. Manufacturing?," Council On Foreign Relations, May 15, 2020, https://www.cfr.org/blog/irish-shock-us-manufacturing
























Ed Comment:I think what we care about is how much us taxes pharma pays, how many high value-added domestic jobs they create, and the domestic multiplier on those jobs, not where they locate low-value added pill stuffers. Do we want the research jobs offshore or on? He might have a point, but not without pulling his nose off the paper and putting his point into the relevant context.